OMX30 1 510 -0,2%  OMXH25 3 694 0,1%  OMXC20 892 -0,2%  Dow 19 732 -0,4%  Nas 5 051 -0,1%  EUR 9,5367 -0,1%  USD 8,9397 -0,1%  Olja 54,5 0,5%  Guld 1 205 -0,7% 

Baxter International Aktie

46,57USD -0,21USD -0,44%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Baxter International

2015 2016e 2017e 2018e 2019e
Utdelning 0,71 0,52 0,57 0,61 0,69
Direktavkastning (i %) 1,86 1,15 1,27 1,35 1,53
PE-tal 27,68 23,59 21,17 18,31 16,56
Resultat/aktie 1,38 1,91 2,13 2,46 2,72

Nyheter om Baxter International Inc.

ytterligare nyheter

Analyser om Baxter International Inc.

ytterligare analyser

Baxter International Peer Group

Baxter International 46,57
-0,4%
Boston Scientific 23,88
-0,2%
Cardinal Health 75,55
-0,3%
Fresenius Medical Care 75,61
-0,3%
Fresenius 73,43
-0,6%
Medtronic 75,29
-0,5%
STRATEC Biomedical 45,95
-0,1%
pagehit

Lägg till instrument

Vad tycker du?

Profil Baxter International Inc.

till bolagsprofilen
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctor's offices and by patients at home under physician supervision. It operates through the following segments: Hospital Products and Renal. The Hospital Products segment intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation. The Renal segment provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis, home HD, continuous renal replacement therapy and additional dialysis services. Baxter International was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Realtidskurs Baxter International Inc.

Bid
46,58
USD
Ask
46,59
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Baxter International Inc. i USDPUSH CHART

Kurs 46,57 USD -0,21 -0,44 %
Kurstid 21:59:57
Datum 19.01.2017
Öppning 46,62
Gårdagen 46,57
Dagshögsta 46,66
Dagslägsta 46,28
52 v. högsta 50,15
52 v. lägsta 34,07
52 v. perf.
Volym (Antal) 103 929
Börsvärde (SEK) 226,04 Mrd
Börsen
Kurs för 46,57 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 416,28 SEK.

Till aktien Baxter International

Ticker
ISIN US0718131099
Index S&P 500, S&P 100, NYSE US 100, BX Swiss - USA

Baxter International Nyckeltal

Börsvärde i SEK 226,04 Mrd
Free float % 99,69
Antal aktier mio. 543,92
Cashflow/aktie i lokal valuta 2,33
Bokvärde/aktie i lokal valuta 15,70
60 dagar vola 30,42
PBV 2,43

Baxter International Historiska kurser

2017-01-19 46,57 103 929
2017-01-18 46,77 143 817
2017-01-17 46,51 153 117
2017-01-13 46,44 82 422
2017-01-12 46,50 162 975